Boston Scientific Corp (BSX) earnings · P/E 18, rev $20.07B
These earnings events as JSON? API free 100/dayBoston Scientific Corp (BSX) is a medical devices company listed on US.
This BSX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. Revenue was up 19.9% from 2024-12-31 to 2025-12-31. BSX currently screens at market cap $71.81B and trailing P/E 17.9.
When the next BSX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 19.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BSX research stays on the stock page; the tape stays on the quote page.
BSX earnings FAQ
What are BSX's latest revenue and net income?
Latest cached Boston Scientific Corp (BSX) revenue for Dec 31, 2025 was $20.07B. Net income was $2.89B. Statements: https://lician.com/financials/bsx
What is BSX's latest diluted EPS?
Latest cached Boston Scientific Corp (BSX) diluted EPS for Dec 31, 2025 was $1.94.
What period does the latest BSX earnings print cover?
The latest cached Boston Scientific Corp (BSX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BSX revenue change from the prior cached period?
Cached Boston Scientific Corp (BSX) revenue was up 19.9% from $16.75B (Dec 31, 2024) to $20.07B (Dec 31, 2025). Statements: https://lician.com/financials/bsx
What is BSX's P/E ratio?
Boston Scientific Corp (BSX) trailing P/E is 17.9 on the latest cached fundamentals snapshot.
Where are BSX earnings listed?
Cached earnings facts for Boston Scientific Corp (BSX) are listed at https://lician.com/earnings/bsx. Statements: https://lician.com/financials/bsx
Not investment advice.